Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

AGM Statement

17 May 2010 07:00

RNS Number : 9981L
Cello Group plc
17 May 2010
 



17 May 2010

 

Cello Group plc

 

AGM statement

 

Cello Group (AIM: CLL, 'Cello', or 'the Group'), the leading independent market research and consulting group, announces that at the General Meeting this afternoon, Chairman Allan Rich will say:

 

"We have continued to make a solid recovery in our profitability in the first quarter of the year, continuing the trend of our stronger fourth quarter in the last financial year.

 

"Client activity in research has settled into a more normal pattern after the disruption seen last year, with a notably strong performance in health related activity and from international research mandates. Our Tangible division is also performing as expected.

 

"Across the group we are benefiting from the overhead reduction programme implemented during 2009, particularly where we consolidated operations into larger professional hubs.

 

"The Group has therefore performed strongly during the first quarter of 2010. While there remains economic uncertainty, we are growing in confidence about the Group's performance."

 

Enquiries:

 

Cello Group

 020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Finance Director

Altium

 020 7484 4040

Ben Thorne

Paul Chamberlain

College Hill

 020 7457 2020

Adrian Duffield/Rozi Morris

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMGGUQUAUPUGMC
Date   Source Headline
14th May 20137:00 amRNSBoard Appointment
14th May 20137:00 amRNSAGM STATEMENT
10th May 20132:28 pmRNSAdditional Listing/TVR
23rd Apr 20137:00 amRNSHolding(s) in Company
19th Apr 20137:00 amRNSFace Launches Pulsar TRAC
12th Apr 20131:03 pmRNSAnnual Report and Accounts 2012
9th Apr 20137:00 amRNSDirector/PDMR Shareholding
2nd Apr 201312:44 pmRNSHolding(s) in Company
27th Mar 201310:00 amRNSHolding(s) in Company
20th Mar 20137:00 amRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSPreliminary Results for the Year Ended 31 Dec 2012
1st Mar 20137:00 amRNSTotal Voting Rights
28th Jan 20137:00 amRNSPre-close trading update
28th Jan 20137:00 amRNSAcquisition of Mash Health
19th Dec 20129:50 amRNSHolding(s) in Company
14th Nov 20127:00 amRNSHealthcare Seminar
1st Oct 201212:29 pmRNSShare Option Grants
20th Sep 20129:09 amRNSDirector/PDMR Shareholding
19th Sep 20122:13 pmRNSDividend Timetable
19th Sep 20127:01 amRNSCello's Talking Taboos
19th Sep 20127:00 amRNSInterim Results 2012
3rd Sep 20128:30 amRNSNotice of Interim results
12th Jul 20122:21 pmRNSShare Option Grants
11th Jul 20127:00 amRNSTrading update
1st Jun 20127:00 amRNSTotal Voting Rights
24th May 20127:00 amRNSAdditional listing / TVR
16th May 201210:07 amRNSResult of AGM
15th May 20127:00 amRNSAGM Statement
1st May 20127:00 amRNSAdditional Listing
17th Apr 20127:00 amRNSAnnual Financial Report
27th Mar 20127:00 amRNSHolding(s) in Company
14th Mar 20127:00 amRNSDirector/PDMR Shareholding
13th Mar 20127:00 amRNSLaunch of CSR programme
13th Mar 20127:00 amRNSFinal Results
24th Jan 201212:59 pmRNSNotice of Results
23rd Jan 20127:01 amRNSYear end trading update
21st Dec 20117:00 amRNSDirectorate Change
19th Dec 20117:00 amRNSChange of Adviser
1st Nov 201111:30 amRNSHolding in Company
18th Oct 20117:00 amRNSHolding in Company
4th Oct 20117:00 amRNSDirector/PDMR Shareholding
21st Sep 201110:30 amRNSDirector/PDMR Shareholding
10th Aug 201110:37 amRNSNotice of Results
13th Jul 20117:00 amRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSTrading update
14th Jun 20117:00 amRNSShare Option Grants
3rd Jun 201110:10 amRNSTotal Voting Rights
26th May 20117:00 amRNSAnalyst and investor teach-in
17th May 20111:23 pmRNSResult of AGM
17th May 20117:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.